Genetic Variations of AKT1 are Associated with Risk Screening for Non-Alcoholic Fatty Liver Disease

References

• Xue R, Yang RX, Fan JG. Epidemiological trends and clinical characteristic of NAFLD/MAFLD in Asia. J Dig Dis. 2022;23(7):354–357. doi:10.1111/1751-2980.13117
   PubMed Web of Science ®Google Scholar
• Paik JM, Kabbara K, Eberly KE, Younossi Y, Henry L, Younossi ZM. Global burden of NAFLD and chronic liver disease among adolescents and young adults. Hepatology. 2022;75(5):1204–1217. doi:10.1002/hep.32228
   PubMed Web of Science ®Google Scholar
• Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212–2224. doi:10.1016/s0140-6736(20)32511-3
   PubMed Web of Science ®Google Scholar
• Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851–1864. doi:10.1053/j.gastro.2020.01.052
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14(1):32–42. doi:10.1038/nrgastro.2016.147
   PubMed Web of Science ®Google Scholar
• Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut. 2020;69(9):1691–1705. doi:10.1136/gutjnl-2020-320622
   PubMed Web of Science ®Google Scholar
• Marcuccilli M, Chonchol M. NAFLD and chronic kidney disease. Int J Mol Sci. 2016;17(4):562. doi:10.3390/ijms17040562
   PubMed Web of Science ®Google Scholar
• Huang R, Fan JG, Shi JP, et al. Health-related quality of life in Chinese population with non-alcoholic fatty liver disease: a national multicenter survey. Health Qual Life Outcomes. 2021;19(1):140. doi:10.1186/s12955-021-01778-w
   PubMed Web of Science ®Google Scholar
• Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908–922. doi:10.1038/s41591-018-0104-9
   PubMed Web of Science ®Google Scholar
• Meroni M, Longo M, Rustichelli A, Dongiovanni P. Nutrition and genetics in NAFLD: the perfect binomium. Int J Mol Sci. 2020;21(8):2986. doi:10.3390/ijms21082986
   PubMed Web of Science ®Google Scholar
• Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–2014.e1. doi:10.1053/j.gastro.2019.11.312
   PubMed Web of Science ®Google Scholar
• Jeong SH, Kim HB, Kim MC, et al. Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer. J Clin Invest. 2018;128(3):1010–1025. doi:10.1172/jci95802
   PubMed Web of Science ®Google Scholar
• Manning BD, Toker A. AKT/PKB signaling: navigating the network. Cell. 2017;169(3):381–405. doi:10.1016/j.cell.2017.04.001
   PubMed Web of Science ®Google Scholar
• Di Lorenzo A, Fernández-Hernando C, Cirino G, Sessa WC. Akt1 is critical for acute inflammation and histamine-mediated vascular leakage. Proc Natl Acad Sci U S A. 2009;106(34):14552–14557. doi:10.1073/pnas.0904073106
   PubMed Web of Science ®Google Scholar
• Cohen MM Jr. The AKT genes and their roles in various disorders. Am J Med Genet A. 2013;161(12):2931–2937. doi:10.1002/ajmg.a.36101
   Web of Science ®Google Scholar
• Avan A, Avan A, Le Large TY, et al. AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients. PLoS One. 2014;9(9):e108057. doi:10.1371/journal.pone.0108057
   PubMed Web of Science ®Google Scholar
• Wan M, Easton RM, Gleason CE, et al. Loss of Akt1 in mice increases energy expenditure and protects against diet-induced obesity. Mol Cell Biol. 2012;32(1):96–106. doi:10.1128/mcb.05806-11
   PubMed Web of Science ®Google Scholar
• Heljić M, Brazil DP. Protein kinase B/Akt regulation in diabetic kidney disease. Front Biosci. 2011;3(1):98–104. doi:10.2741/s135
   Google Scholar
• Yin X, Xu Z, Zhang Z, et al. Association of PI3K/AKT/mTOR pathway genetic variants with type 2 diabetes mellitus in Chinese. Diabetes Res Clin Pract. 2017;128:127–135. doi:10.1016/j.diabres.2017.04.002
   PubMed Web of Science ®Google Scholar
• McKenzie JA, Witkowski S, Ludlow AT, Roth SM, Hagberg JM. AKT1 G205T genotype influences obesity-related metabolic phenotypes and their responses to aerobic exercise training in older Caucasians. Exp Physiol. 2011;96(3):338–347. doi:10.1113/expphysiol.2010.055400
   PubMed Web of Science ®Google Scholar
• Eshaghi FS, Ghazizadeh H, Kazami-Nooreini S, et al. Association of a genetic variant in AKT1 gene with features of the metabolic syndrome. Genes Dis. 2019;6(3):290–295. doi:10.1016/j.gendis.2019.03.002
   PubMed Web of Science ®Google Scholar
• National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update. Zhonghua Gan Zang Bing Za Zhi. 2018;26(3):195–203. doi:10.3760/cma.j.issn.1007-3418.2018.03.008
   PubMedGoogle Scholar
• Woods NT, Monteiro AN, Thompson ZJ, et al. Interleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients. Mol Carcinog. 2015;54(1):E172–184. doi:10.1002/mc.22275
   PubMedGoogle Scholar
• Chinese obesity working group. Prevention and control guide on overweight and obesity in Chinese adults (excerpt). Acta Nutrimenta Sinica. 2004;2004(1):1–4.
   Google Scholar
• Joint Committee for Guideline Revision. 2016 Chinese guideline for the management of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi. 2016;44(10):833–853. doi:10.3760/cma.j.issn.0253-3758.2016.10.005
   PubMedGoogle Scholar
• Joint Committee for Guideline Revision. 2018 Chinese guidelines for prevention and treatment of hypertension-A report of the revision committee of Chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol. 2019;16(3):182–241. doi:10.11909/j.issn.1671-5411.2019.03.014
   PubMedGoogle Scholar
• Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet. 2004;36(2):131–137. doi:10.1038/ng1296
   PubMed Web of Science ®Google Scholar
• Chen WS, Xu PZ, Gottlob K, et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 2001;15(17):2203–2208. doi:10.1101/gad.913901
   PubMed Web of Science ®Google Scholar
• Chu CY, Chen CF, Rajendran RS, et al. Overexpression of Akt1 enhances adipogenesis and leads to lipoma formation in zebrafish. PLoS One. 2012;7(5):e36474. doi:10.1371/journal.pone.0036474
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism. 2019;92:82–97. doi:10.1016/j.metabol.2018.11.014
   PubMed Web of Science ®Google Scholar
• Karege F, Méary A, Perroud N, et al. Genetic overlap between schizophrenia and bipolar disorder: a study with AKT1 gene variants and clinical phenotypes. Schizophr Res. 2012;135(1–3):8–14. doi:10.1016/j.schres.2011.12.015
   PubMed Web of Science ®Google Scholar
• Morgan CJ, Freeman TP, Powell J, Curran HV. AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers. Transl Psychiatry. 2016;6(2):e738. doi:10.1038/tp.2015.219
   PubMed Web of Science ®Google Scholar
• Li Y, Zhu L, Yao H, et al. Association of inflammation-related gene polymorphisms with susceptibility and radiotherapy sensitivity in head and neck squamous cell carcinoma patients in Northeast China. Front Oncol. 2021;11:651632. doi:10.3389/fonc.2021.651632
   PubMed Web of Science ®Google Scholar
• Jin Y, Yuan Y, Yi M, Han H, Liu B, Li Q. Phosphorylated-Akt overexpression is associated with a higher risk of brain metastasis in patients with non-small cell lung cancer. Biochem Biophys Rep. 2019;18:100625. doi:10.1016/j.bbrep.2019.100625
   PubMedGoogle Scholar
• Liemburg EJ, Bruins J, van Beveren N, Islam MA, Alizadeh BZ. Cannabis and a lower BMI in psychosis: what is the role of AKT1? Schizophr Res. 2016;176(2–3):95–99. doi:10.1016/j.schres.2016.08.014
   PubMed Web of Science ®Google Scholar
• Li L, You W, Ren W. The ZJU index is a powerful index for identifying NAFLD in the general Chinese population. Acta Diabetol. 2017;54(10):905–911. doi:10.1007/s00592-017-1024-8
   PubMed Web of Science ®Google Scholar
• Chung TH, Kim JK, Kim JH, Lee YJ. Fatty liver index as a simple and useful predictor for 10-year cardiovascular disease risks determined by Framingham risk score in the general Korean population. J Gastrointestin Liver Dis. 2021;30(2):221–226. doi:10.15403/jgld-3404
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503–508. doi:10.1016/j.dld.2009.08.002
   PubMedGoogle Scholar
• Chen C, Zhu Z, Mao Y, et al. HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels. Biosci Rep. 2020;40(1). doi:10.1042/bsr20193996
   Google Scholar
• Wang Z, Fu H, Li W. Association between AKT rs2494752 single nucleotide polymorphism and the risk of metastasis in hepatocellular carcinoma. Oncol Lett. 2018;16(3):3699–3705. doi:10.3892/ol.2018.9060
   PubMed Web of Science ®Google Scholar
• Zhu J, Wang M, He J, et al. Polymorphisms in the AKT1 and AKT2 genes and oesophageal squamous cell carcinoma risk in an Eastern Chinese population. J Cell Mol Med. 2016;20(4):666–677. doi:10.1111/jcmm.12750
   PubMed Web of Science ®Google Scholar
• Wang MY, He J, Zhu ML, et al. A functional polymorphism (rs2494752) in the AKT1 promoter region and gastric adenocarcinoma risk in an Eastern Chinese population. Sci Rep. 2016;6:20008. doi:10.1038/srep20008
   PubMed Web of Science ®Google Scholar
• Li X, Zhang R, Liu Z, Li S, Xu H. The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes. Oncotarget. 2017;8(12):20252–20265. doi:10.18632/oncotarget.15690
   PubMedGoogle Scholar
• Xu JL, Wang ZW, Hu LM, et al. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population. Asian Pac J Cancer Prev. 2012;13(5):2157–2162. doi:10.7314/apjcp.2012.13.5.2157
   PubMedGoogle Scholar
• Kermanshahi F, Ghazizadeh H, Hussein NA, et al. Association of a genetic variant in the AKT gene locus and cardiovascular risk factors. Cell Mol Biol. 2020;66(3):57–64. doi:10.14715/cmb/2020.66.3.9
   PubMed Web of Science ®Google Scholar
• Zhou F, Zhou J, Wang W, et al. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis. Hepatology. 2019;70(4):1119–1133. doi:10.1002/hep.30702
   PubMed Web of Science ®Google Scholar
• Hu XY, Li Y, Li LQ, et al. Risk factors and biomarkers of non-alcoholic fatty liver disease: an observational cross-sectional population survey. BMJ Open. 2018;8(4):e019974. doi:10.1136/bmjopen-2017-019974
   PubMed Web of Science ®Google Scholar
• Chinese Diabetes Society: Metabolic Syndrome Cooperative Study Group. The suggestion about metabolic syndrome from Chinese diabetes society. Chin J Diabetes Mellitus. 2004;12(3):156–161.
   Google Scholar
• Liu Z, Que S, Xu J, Peng T. Alanine aminotransferase-old biomarker and new concept: a review. Int J Med Sci. 2014;11(9):925–935. doi:10.7150/ijms.8951
   PubMed Web of Science ®Google Scholar